Zealand Pharma, a Denmark-based drugmaker, will acquire “substantially all” of Valeritas’ assets for $23 million, according to a Feb. 9 news release.
Valeritas manufactures the V-Go wearable insulin delivery device.
The company said it will continue operations as normal during the transaction with Zealand.
Read the full news release here.
More articles on supply chain:
Coronavirus will cost Boston Scientific $10M to $40M in Q1, company says
Premier acquires New York Hospital Association’s GPO
Tennessee hospital lab manager quits, says hospital regularly ran out of critical supplies
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
